GGrantIndex
← Leaderboards

Henry Rusinek

New York University School Of Medicine

$7,024,952
Attributed
$10,566,667
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,566,667 · 9

By mechanism

R01$6,222,429 · 2
P30$2,321,921 · 3
U24$1,154,856 · 1
R56$861,001 · 1
M01$6,460 · 2

Top collaborators

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposImageMagnetic Resonance ImagingBrainPerfusionNeuropathologyBaseS DiseaseBlood VesselsCarbon DioxideQuality ControlFutureAmyloid Beta-ProteinImpaired CognitionHippocampus (Brain)DiagnosisMeasurementPositron-Emission TomographyBiological MarkersAmyloidAgingFundingSamplingTau Proteins

Grant awards (25)

Neuroimaging Core$158,906
P30 · FY2025 · AG · contact PI
Neuroimaging Core$293,255
P30 · FY2024 · AG · contact PI
Neuroimaging Core$293,093
P30 · FY2023 · AG · contact PI
Neuroimaging Core$322,940
P30 · FY2022 · AG · contact PI
Advanced Software for MRI, PET, SPECT and CT Image Analysis$360,321
U24 · FY2021 · EB · contact PI
Neuroimaging Core$314,068
P30 · FY2021 · AG · contact PI
Advanced Software for MRI, PET, SPECT and CT Image Analysis$370,785
U24 · FY2020 · EB · contact PI
Neuroimaging Core$315,170
P30 · FY2020 · AG · contact PI
Advanced Software for MRI, PET, SPECT and CT Image Analysis$423,750
U24 · FY2019 · EB · contact PI
Core F: Neuroimaging Core$316,312
P30 · FY2019 · AG · contact PI
CSF Clearance with 11C-Butanol PET Predicts Amyloid Deposition$538,931
R56 · FY2018 · AG
CSF Clearance with 11C-Butanol PET Predicts Amyloid Deposition$322,070
R56 · FY2018 · AG
Core F: Neuroimaging Core$308,177
P30 · FY2016 · AG · contact PI
Biomarkers in Early Alzheimer's Disease (AD).$620,385
R01 · FY2015 · AG
MRI Progression Markers of Cognitive Decline in the Elderly$618,546
R01 · FY2015 · AG
Biomarkers in Early Alzheimer's Disease (AD).$618,270
R01 · FY2013 · AG
MRI Progression Markers of Cognitive Decline in the Elderly$586,669
R01 · FY2013 · AG
Biomarkers in Early Alzheimer's Disease (AD).$644,278
R01 · FY2012 · AG
MRI Progression Markers of Cognitive Decline in the Elderly$621,867
R01 · FY2012 · AG
Biomarkers in Early Alzheimer's Disease (AD).$617,985
R01 · FY2011 · AG
MRI Progression Markers of Cognitive Decline in the Elderly$611,117
R01 · FY2011 · AG
MRI Progression Markers of Cognitive Decline in the Elderly$678,660
R01 · FY2010 · AG
Biomarkers in Early Alzheimer's Disease (AD).$604,652
R01 · FY2010 · AG
ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE$5,524
M01 · FY2007 · RR · contact PI
ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE$936
M01 · FY2006 · RR · contact PI